Active ingredientGivinostatCat. No. P-G035-001CAS 497833-27-9Family · Pharmaceutical analytical standards
Givinostat
An inhibitor of histone deacetylases (HDACs), enzymes that regulate gene expression: it reduces inflammation and muscle degeneration and was approved in the United States in March 2024 for Duchenne muscular dystrophy from 6 years of age. This family brings together the active ingredient, metabolites, labelled standards and other impurities.
Did you know?It was the first non-steroidal medicine approved by the FDA for Duchenne in all patients, whatever the mutation in the dystrophin gene that causes the disease.
Go to the active ingredient →Active ingredientGivinostatCat. No. P-G035-001CAS 497833-27-9
MetaboliteGivinostat-O-GlucuronideCat. No. P-G035-002
Isotopically labelledGivinostat Impurity 1 Hydrochloride-d10Cat. No. P-G035-003
Isotopically labelledGivinostat Impurity 3-d4Cat. No. P-G035-004
Isotopically labelledGivinostat Impurity 4-d10Cat. No. P-G035-005
Isotopically labelledGivinostat Impurity 2-d10Cat. No. P-G035-006
Isotopically labelledGivinostat Impurity 5-d4Cat. No. P-G035-007
Isotopically labelledGivinostat-d10Cat. No. P-G035-008
Isotopically labelledGivinostat-d10-O-GlucuronideCat. No. P-G035-009
Impurity4-(Acetylamino)benzamideCat. No. P-G035-010CAS 58202-83-8
Impurity4-Acetylaminohippuric acidCat. No. P-G035-011CAS 1984-38-9
ImpurityGivinostat Acid ImpurityCat. No. P-G035-012CAS 199657-47-1
ImpurityGivinostat Impurity 1 HydrochlorideCat. No. P-G035-013
ImpurityGivinostat Impurity 2Cat. No. P-G035-014No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.